跳至主要内容
临床试验/NCT06836908
NCT06836908已完成不适用

Chest Compression Synchronized Ventilation (CCSV) - An Exploratory Post Market Clinical Follow-up Study

Medical University of Vienna1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2024年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
50
试验地点
1
主要终点
Oxygenation

研究概览

简要总结

The main goal of this observational study is the evaluation of Chest Compression Synchronized Ventilation (CCSV) regarding oxygenation in terms of PaO2 assessed by routine blood gas analysis, hemodynamic effects, 30-day outcome and safety in comparison to Intermittent Positive Pressure Ventilation (IPPV) as data in humans is sparse especially in direct comparison to other ventilation modes.

Cardiac arrest patients in Vienna, Austria will be preclinically randomized (IPPV and CCSV) and ventilated accordingly during CPR. Differences in oxygenation, decarboxylation, systemic perfusion and cerebral oxygenation, the patient's 30-day outcome as well as ventilator-associated adverse events (e.g., pneumothorax) will be recorded and analyzed.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Correct endotracheal intubation (seen by capnography)
  • The patient is being treated by the Vienna Emergency Medical Services within the scope of emergency ventilation.
  • MEDUMAT Standard from Weinmann Emergency is used.
  • Mechanical ventilation is performed according to the specified indications.

排除标准

  • Patients eligible for eCPR (as defined by the standard operating procedure of the Emergency Medical Service Vienna)
  • Patients recovering (reaching sustained ROSC) before starting mechanical ventilation or in the first three minutes of it
  • Any other mechanical ventilation during the ongoing CPR before study inclusion
  • Traumatic cardiac arrest
  • Suspected or known pregnancy
  • Clinically suspected (tension-)pneumothorax

结局指标

主要结局

Oxygenation

时间窗: 24 months

Difference in PaO2 between IPPV and CCSV group

次要结局

  • systemic perfusion(24 months)
  • Decarboxylation(24 months)
  • patient outcome(27 months)
  • ventilator-associated adverse events(27 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sebastian Schnaubelt, MD

Adjunct Professor

Medical University of Vienna

研究点 (1)

Loading locations...

相似试验